Overview
Financials
Revenue history
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 380 days for 2024).
- 202530/07/2026
- 202430/07/2026
- 202325/07/2024
- 202201/07/2023
- 202131/08/2022
- 202001/08/2021
The statements for 2024–2025 report only zeros (no activity).
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board has the right to represent the company independently. In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Joanna Wanda Tkaczuk Włachage 50 | 47 | $1,269.58 | 94% |
Others | 3 | $81.04 | 6% |
Beneficial owners
No beneficial owners recorded for the company Fungi Biomed.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Sylvecosp. z o.o. | $8,294,667.74 | sylveco.pl | ||
| Red Pharma Laboratories PolskaS.A. | $1,369,528.53 | red-pharma.com | ||
| ADEX Holding Sierdzińskisp. j. | $419,753.27 | adexcosmetics.com | ||
| Rebread Cosmeticssp. z o.o. | $7,516.91 | rebread.com | ||
| Admedicsp. z o.o. | $4,842.61 | admedic.pl | ||
| Melanos Caresp. z o.o. | $8.49 | melanoscare.com | ||
| Nuaréskynsp. z o.o. | $0.00 | nuareskyn.com | ||
| EMEZsp. z o.o. | $0.00 | biodermic.pl | ||
| MCS Laboratorysp. z o.o. | $0.00 | mcslaboratory.com | ||
| KairisP.S.A. | – | kairis.pl |
FAQ
Last updated: 2026-07-30